Perrigo Company PLC Stock TEL AVIV STOCK EXCHANGE
Stocks
IE00BGH1M568
Pharmaceuticals
| Market Cap | 1.4B 4.21B 1.23B 1.13B 1.04B 1.97B 135B 2.01B 13.52B 5.31B 66.05B 5.27B 5.16B 228B | P/E 2026 * |
-72.5x | P/E 2027 * | 8.75x |
|---|---|---|---|---|---|
| Enterprise Value | 4.34B 13.01B 3.8B 3.5B 3.22B 6.1B 418B 6.21B 41.82B 16.41B 204B 16.31B 15.95B 704B | EV / Sales 2026 * |
1.07x | EV / Sales 2027 * | 1.03x |
| Free-Float |
99.6% | Yield 2026 * |
11.4% | Yield 2027 * | 11.7% |
Last Transcript: Perrigo Company PLC
| 1 day | -1.32% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Manzone
CEO | Chief Executive Officer | 63 | 2026-06-06 |
Eduardo Bezerra
DFI | Director of Finance/CFO | 51 | 2022-05-15 |
Matt Winterman
COO | Chief Operating Officer | - | 2025-06-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Donal O'Connor
BRD | Director/Board Member | 75 | 2014-10-31 |
Geoffrey Parker
BRD | Director/Board Member | 61 | 2016-11-06 |
Bradley Alford
BRD | Director/Board Member | 70 | 2017-02-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -1.36% | - | - | 1.37B | |
| +0.35% | -4.87% | +49.87% | +157.34% | 1,028B | |
| -2.69% | -6.22% | +59.19% | +54.51% | 611B | |
| +0.44% | -3.41% | +30.97% | +79.48% | 432B | |
| +0.98% | -1.40% | +29.49% | +21.76% | 323B | |
| -0.34% | -3.10% | +27.00% | +43.60% | 277B | |
| +1.63% | -11.76% | +19.72% | +21.72% | 257B | |
| +3.39% | +2.29% | -23.68% | -37.83% | 217B | |
| +0.86% | -2.63% | +22.50% | +57.55% | 192B | |
| +1.28% | -3.03% | +20.76% | +70.62% | 161B | |
| Average | +0.46% | -4.60% | +26.20% | +52.08% | 388.7B | |
| Weighted average by Cap. | +0.19% | -4.85% | +35.86% | +76.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.06B 12.15B 3.55B 3.27B 3.01B 5.7B 390B 5.8B 39.06B 15.32B 191B 15.23B 14.9B 658B | 4.1B 12.28B 3.58B 3.31B 3.04B 5.76B 394B 5.86B 39.46B 15.48B 193B 15.39B 15.05B 664B |
| Net income | -339M -1.02B -296M -273M -251M -476M -32.62B -484M -3.26B -1.28B -15.94B -1.27B -1.25B -54.95B | 161M 484M 141M 130M 120M 227M 15.53B 231M 1.55B 610M 7.59B 606M 593M 26.16B |
| Net Debt | 2.94B 8.8B 2.57B 2.37B 2.18B 4.13B 283B 4.2B 28.3B 11.1B 138B 11.04B 10.8B 476B | 2.83B 8.47B 2.47B 2.28B 2.1B 3.97B 272B 4.04B 27.23B 10.68B 133B 10.62B 10.39B 458B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
